Going concern
Filing comparison
Aprea Therapeutics, Inc.'s going-concern disclosure changed
Substantial doubt about ability to continue as a going concern → Risk-factor language only
… efforts. ● Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and our financial condition and results of operations. ● We have identified conditions and events that raise substantial doubt regarding our ability to continue as a going concern. Risks related to the discovery, development and commercialization of our product candidates ● We are substantially dependent on…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- risk_factor_only
- Current state label
- Risk-factor language only
- Direction
- eased
- Located in
- risk factors / forward-looking statements only
- Prior filed
- 2025-11-12
- Prior form
- 10-Q
- Prior state
- substantial_doubt
- Prior state label
- Substantial doubt about ability to continue as a going concern
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.